A nationwide survey of newly diagnosed childhood idiopathic thrombocytopenic purpura in Japan

Journal of Pediatric Hematology/Oncology

Volumn 31, Issue 1, 2009, Pages 27-32

  Shirahata, Akira ^a,n   Fujisawa, Kohji ^b   Ishii, Eiichi ^c   Ohta, Shigeru ^d   Sako, Masahiro ^e   Takahashi, Yukihiro ^f   Taki, Masashi ^g   Mimaya, Jun Ichi ^h   Kubota, Masaru ⁱ   Miura, Takuma ^j   Kitazawa, Junichi ^k   Kajiwara, Michiko ^l   Bessho, Fumio ^m  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b Fujisawa Clinic for Children   (Japan)

^c EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^e OSAKA CITY GENERAL HOSPITAL   (Japan)

^f NARA MEDICAL UNIVERSITY HOSPITAL   (Japan)

^g ST MARIANNA UNIVERSITY   (Japan)

^h SHIZUOKA CHILDREN'S HOSPITAL   (Japan)

ⁱ NARA WOMEN'S UNIVERSITY   (Japan)

^j Department of Pediatrics

^k Kuroishi General Hospital   (Japan)

^l TOKYO MEDICAL AND DENTAL UNIVERSITY HOSPITAL   (Japan)

^m KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁿ UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

more..

Author keywords

Clinical outcome; Corticosteroid; Guideline; Intravenous immunoglobulin; Platelet

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN;

ARTICLE; ASEPTIC MENINGITIS; BLEEDING; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEADACHE; HEALTH SURVEY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFANT; JAPAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; THROMBOCYTE COUNT; ADOLESCENT; QUESTIONNAIRE;

ADOLESCENT; CHILD; FEMALE; HEALTH SURVEYS; HUMANS; JAPAN; MALE; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; QUESTIONNAIRES;

EID: 59449102893     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e318190d44e     Document Type: Article

References (22)

1. Nugent DJ. Immune thrombocytopenic purpura: why treat? J Pediatr. 1999;134:3-4.
2. Lilleyman JS. Management of childhood idiopathic thrombo-cytopenic purpura Br J Haematol. 1999;105:871-875.
3. Tarantino MD. Treatment options for chronic immune (idiopathic) thrombocytopenic purpura in children. Semin Hematol. 2000;37(suppl 1):35-41.
4. Bolton-Maggs PHB. Idiopathic thrombocytopenic purpura. Arch Dis Child. 2000;83:220-222.
5. Yu-Waye C, Korb J, Sakamoto KM. Idiopathic thrombocytopenic purpura. Pediatr Rev. 2000;21:95-103.
6. Buchanan GR. Idiopathic thrombocytopenic purpura in childhood. Pediatr Ann. 2001;30:527-533.
7. de Alarcon PA. Immune or idiopathic thrombocytopenic purpura (ITP) in childhood: what are the risks and who should be treated? J Pediatr. 2003;143:287-289.
8. Lilleyman J. Medical nemesis and childhood ITP. Br J Haematol. 2003;123:586-589.
9. Eden OB, Lilleyman JS. Guidelines for management of idiopathic thrombocytopenic purpura. Arch Dis Child. 1992;67: 1056-1058.
10. Bolton-Maggs PHB, Moon I. Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines. Lancet. 1997;350: 620-623.
11. Vesely S, Buchanan GR, Cohen A, et al. Self-reported diagnostic and management strategies in childhood idiopathic thrombocytopenic purpura: results of a survey of practicing pediatric hematology/oncology specialists. J Pediatr Hematol Oncol. 2000;22:55-61.
12. Kuramoto A. Report of idiopathic thrombocytopenic purpura. The Research Group for Intractable Hematopoietic Disorders supported by the Ministry of Health and Welfare. 1991:59-63.
13. Kühne T, Imbach P, Bolton-Maggs PHB, et al. Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet. 2001;358:2122-2125.
14. Zeller B, Helgestad J, Hellebostad M, et al. Immune thrombocytopenic purpura in childhood in Norway: a prospective, population-based registration. Pediatr Hematol Oncol. 2000;17:551-558.
15. Zeller B, Rajantie J, Hedhund-Treutiger I, et al. Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease. Acta Paediatr. 2005;94:178-184.
16. Imbach P, Kuhne T, Müller D, et al. Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS). Pediatr Blood Cancer. 2006;46:351-356.
17. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88:3-40.
18. Mattia DD, Principe DD, Del Vecchio GC, et al. Acute childhood idiopathic thrombocytopenic purpura: AIEOP consensus guidelines for diagnosis and treatment. Hematologica. 2000;85:420-424.
19. British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol. 2003;120: 574-596.
20. Fujisawa K, Iyori H, Ohkawa H, et al. A prospective, randomized trial of conventional, dose-accelerated corticoster-oids and intravenous immunoglobulin in children with newly diagnosed idiopathic thrombocytopenic purpura. Int J Hematol. 2000;72:376-383.
21. Shirahata A, Ishii E, Eguchi H, et al. Consensus guideline for diagnosis and treatment of childhood idiopathic thrombocy-topenic purpura. Jpn J Pediatr Hematol. 2004;18:210-218.
22. Shirahata A, Ishii E, Eguchi H, et al. Consensus guideline for diagnosis and treatment of childhood idiopathic thrombocy-topenic purpura. Int J Hematol. 2006;83:29-38.